Comparison of various insulin resistance surrogates on prognostic prediction and stratification following percutaneous coronary intervention in patients with and without type 2 diabetes mellitus

Abstract Background Insulin resistance (IR), evaluation of which is difficult and complex, is closely associated with cardiovascular disease. Recently, various IR surrogates have been proposed and proved to be highly correlated with IR assessed by the gold standard. It remains indistinct whether dif...

Full description

Bibliographic Details
Main Authors: Qi Zhao, Yu-Jing Cheng, Ying-Kai Xu, Zi-Wei Zhao, Chi Liu, Tie-Nan Sun, Yu-Jie Zhou
Format: Article
Language:English
Published: BMC 2021-09-01
Series:Cardiovascular Diabetology
Subjects:
Online Access:https://doi.org/10.1186/s12933-021-01383-7
_version_ 1819063686600327168
author Qi Zhao
Yu-Jing Cheng
Ying-Kai Xu
Zi-Wei Zhao
Chi Liu
Tie-Nan Sun
Yu-Jie Zhou
author_facet Qi Zhao
Yu-Jing Cheng
Ying-Kai Xu
Zi-Wei Zhao
Chi Liu
Tie-Nan Sun
Yu-Jie Zhou
author_sort Qi Zhao
collection DOAJ
description Abstract Background Insulin resistance (IR), evaluation of which is difficult and complex, is closely associated with cardiovascular disease. Recently, various IR surrogates have been proposed and proved to be highly correlated with IR assessed by the gold standard. It remains indistinct whether different IR surrogates perform equivalently on prognostic prediction and stratification following percutaneous coronary intervention (PCI) in non-ST-segment elevation acute coronary syndrome (NSTE-ACS) patients with and without type 2 diabetes mellitus (T2DM). Methods The present study recruited patients who were diagnosed with NSTE-ACS and successfully underwent PCI. IR surrogates evaluated in the current study included triglyceride-glucose (TyG) index, visceral adiposity index, Chinese visceral adiposity index, lipid accumulation product, and triglyceride-to-high density lipoprotein cholesterol ratio, calculations of which were conformed to previous studies. The observational endpoint was defined as the major adverse cardiovascular and cerebrovascular events (MACCE), including cardiac death, non-fatal myocardial infarction, and non-fatal ischemic stroke. Results 2107 patients (60.02 ± 9.03 years, 28.0% female) were ultimately enrolled in the present study. A total of 187 (8.9%) MACCEs were documented during the 24-month follow-up. Despite regarding the lower median as reference [hazard ratio (HR) 3.805, 95% confidence interval (CI) 2.581–5.608, P < 0.001] or evaluating 1 normalized unit increase (HR 1.847, 95% CI 1.564–2.181, P < 0.001), the TyG index remained the strongest risk predictor for MACCE, independent of confounding factors. The TyG index showed the most powerful diagnostic value for MACCE with the highest area under the receiver operating characteristic curve of 0.715. The addition of the TyG index, compared with other IR surrogates, exhibited the maximum enhancement on risk stratification for MACCE on the basis of a baseline model (Harrell’s C-index: 0.708 for baseline model vs. 0.758 for baseline model + TyG index, P < 0.001; continuous net reclassification improvement: 0.255, P < 0.001; integrated discrimination improvement: 0.033, P < 0.001). The results were consistent in subgroup analysis where similar analyses were performed in patients with and without T2DM, respectively. Conclusion The TyG index, which is most strongly associated with the risk of MACCE, can be served as the most valuable IR surrogate for risk prediction and stratification in NSTE-ACS patients receiving PCI, with and without T2DM.
first_indexed 2024-12-21T15:18:37Z
format Article
id doaj.art-3e7028c9ef9042f8bf53d4aeccbe69c7
institution Directory Open Access Journal
issn 1475-2840
language English
last_indexed 2024-12-21T15:18:37Z
publishDate 2021-09-01
publisher BMC
record_format Article
series Cardiovascular Diabetology
spelling doaj.art-3e7028c9ef9042f8bf53d4aeccbe69c72022-12-21T18:59:05ZengBMCCardiovascular Diabetology1475-28402021-09-0120111510.1186/s12933-021-01383-7Comparison of various insulin resistance surrogates on prognostic prediction and stratification following percutaneous coronary intervention in patients with and without type 2 diabetes mellitusQi Zhao0Yu-Jing Cheng1Ying-Kai Xu2Zi-Wei Zhao3Chi Liu4Tie-Nan Sun5Yu-Jie Zhou6Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing Key Laboratory of Precision Medicine of Coronary Atherosclerotic Disease, Clinical Center for Coronary Heart Disease, Capital Medical UniversityDepartment of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing Key Laboratory of Precision Medicine of Coronary Atherosclerotic Disease, Clinical Center for Coronary Heart Disease, Capital Medical UniversityDepartment of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing Key Laboratory of Precision Medicine of Coronary Atherosclerotic Disease, Clinical Center for Coronary Heart Disease, Capital Medical UniversityDepartment of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing Key Laboratory of Precision Medicine of Coronary Atherosclerotic Disease, Clinical Center for Coronary Heart Disease, Capital Medical UniversityDepartment of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing Key Laboratory of Precision Medicine of Coronary Atherosclerotic Disease, Clinical Center for Coronary Heart Disease, Capital Medical UniversityDepartment of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing Key Laboratory of Precision Medicine of Coronary Atherosclerotic Disease, Clinical Center for Coronary Heart Disease, Capital Medical UniversityDepartment of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing Key Laboratory of Precision Medicine of Coronary Atherosclerotic Disease, Clinical Center for Coronary Heart Disease, Capital Medical UniversityAbstract Background Insulin resistance (IR), evaluation of which is difficult and complex, is closely associated with cardiovascular disease. Recently, various IR surrogates have been proposed and proved to be highly correlated with IR assessed by the gold standard. It remains indistinct whether different IR surrogates perform equivalently on prognostic prediction and stratification following percutaneous coronary intervention (PCI) in non-ST-segment elevation acute coronary syndrome (NSTE-ACS) patients with and without type 2 diabetes mellitus (T2DM). Methods The present study recruited patients who were diagnosed with NSTE-ACS and successfully underwent PCI. IR surrogates evaluated in the current study included triglyceride-glucose (TyG) index, visceral adiposity index, Chinese visceral adiposity index, lipid accumulation product, and triglyceride-to-high density lipoprotein cholesterol ratio, calculations of which were conformed to previous studies. The observational endpoint was defined as the major adverse cardiovascular and cerebrovascular events (MACCE), including cardiac death, non-fatal myocardial infarction, and non-fatal ischemic stroke. Results 2107 patients (60.02 ± 9.03 years, 28.0% female) were ultimately enrolled in the present study. A total of 187 (8.9%) MACCEs were documented during the 24-month follow-up. Despite regarding the lower median as reference [hazard ratio (HR) 3.805, 95% confidence interval (CI) 2.581–5.608, P < 0.001] or evaluating 1 normalized unit increase (HR 1.847, 95% CI 1.564–2.181, P < 0.001), the TyG index remained the strongest risk predictor for MACCE, independent of confounding factors. The TyG index showed the most powerful diagnostic value for MACCE with the highest area under the receiver operating characteristic curve of 0.715. The addition of the TyG index, compared with other IR surrogates, exhibited the maximum enhancement on risk stratification for MACCE on the basis of a baseline model (Harrell’s C-index: 0.708 for baseline model vs. 0.758 for baseline model + TyG index, P < 0.001; continuous net reclassification improvement: 0.255, P < 0.001; integrated discrimination improvement: 0.033, P < 0.001). The results were consistent in subgroup analysis where similar analyses were performed in patients with and without T2DM, respectively. Conclusion The TyG index, which is most strongly associated with the risk of MACCE, can be served as the most valuable IR surrogate for risk prediction and stratification in NSTE-ACS patients receiving PCI, with and without T2DM.https://doi.org/10.1186/s12933-021-01383-7Insulin resistance surrogatesType 2 diabetes mellitusNon-ST-segment elevation acute coronary syndromePercutaneous coronary interventionMajor adverse cardiac and cerebrovascular events
spellingShingle Qi Zhao
Yu-Jing Cheng
Ying-Kai Xu
Zi-Wei Zhao
Chi Liu
Tie-Nan Sun
Yu-Jie Zhou
Comparison of various insulin resistance surrogates on prognostic prediction and stratification following percutaneous coronary intervention in patients with and without type 2 diabetes mellitus
Cardiovascular Diabetology
Insulin resistance surrogates
Type 2 diabetes mellitus
Non-ST-segment elevation acute coronary syndrome
Percutaneous coronary intervention
Major adverse cardiac and cerebrovascular events
title Comparison of various insulin resistance surrogates on prognostic prediction and stratification following percutaneous coronary intervention in patients with and without type 2 diabetes mellitus
title_full Comparison of various insulin resistance surrogates on prognostic prediction and stratification following percutaneous coronary intervention in patients with and without type 2 diabetes mellitus
title_fullStr Comparison of various insulin resistance surrogates on prognostic prediction and stratification following percutaneous coronary intervention in patients with and without type 2 diabetes mellitus
title_full_unstemmed Comparison of various insulin resistance surrogates on prognostic prediction and stratification following percutaneous coronary intervention in patients with and without type 2 diabetes mellitus
title_short Comparison of various insulin resistance surrogates on prognostic prediction and stratification following percutaneous coronary intervention in patients with and without type 2 diabetes mellitus
title_sort comparison of various insulin resistance surrogates on prognostic prediction and stratification following percutaneous coronary intervention in patients with and without type 2 diabetes mellitus
topic Insulin resistance surrogates
Type 2 diabetes mellitus
Non-ST-segment elevation acute coronary syndrome
Percutaneous coronary intervention
Major adverse cardiac and cerebrovascular events
url https://doi.org/10.1186/s12933-021-01383-7
work_keys_str_mv AT qizhao comparisonofvariousinsulinresistancesurrogatesonprognosticpredictionandstratificationfollowingpercutaneouscoronaryinterventioninpatientswithandwithouttype2diabetesmellitus
AT yujingcheng comparisonofvariousinsulinresistancesurrogatesonprognosticpredictionandstratificationfollowingpercutaneouscoronaryinterventioninpatientswithandwithouttype2diabetesmellitus
AT yingkaixu comparisonofvariousinsulinresistancesurrogatesonprognosticpredictionandstratificationfollowingpercutaneouscoronaryinterventioninpatientswithandwithouttype2diabetesmellitus
AT ziweizhao comparisonofvariousinsulinresistancesurrogatesonprognosticpredictionandstratificationfollowingpercutaneouscoronaryinterventioninpatientswithandwithouttype2diabetesmellitus
AT chiliu comparisonofvariousinsulinresistancesurrogatesonprognosticpredictionandstratificationfollowingpercutaneouscoronaryinterventioninpatientswithandwithouttype2diabetesmellitus
AT tienansun comparisonofvariousinsulinresistancesurrogatesonprognosticpredictionandstratificationfollowingpercutaneouscoronaryinterventioninpatientswithandwithouttype2diabetesmellitus
AT yujiezhou comparisonofvariousinsulinresistancesurrogatesonprognosticpredictionandstratificationfollowingpercutaneouscoronaryinterventioninpatientswithandwithouttype2diabetesmellitus